Fetal Mild Micromelia

Foot–femur length ratio ≈ 1.15

  • Normal fetal foot length ≈ femur length (ratio ~0.9–1.1)
  • Ratios >1.2–1.3 raise concern for lethal skeletal dysplasias (thanatophoric, severe OI, campomelic)
  • A ratio of 1.15 is:
    • Borderline high
    • Not in the lethal range
    • Consistent with non-lethal, proportionate or mildly disproportionate conditions

It rules out:

  • Thanatophoric dysplasia
  • Severe OI
  • Achondrogenesis
  • Short-rib dysplasia
  • Mild skeletal dysplasia
  • Skeletal dysplasia mimics
  • Syndromic short stature
  • Evolving dysplasia (features appear late)
  • With advancing gestation, the lumbosacral interpedicular distance increases caudally
  • On coronal or axial views, the spine fans out toward the pelvis

In achondroplasia-spectrum conditions:

  • There is failure of normal caudal widening
  • The lumbosacral region appears:
    • Boxy
    • Parallel-sided
    • Sometimes described as "champagne bottle" narrowing postnatally

What trident hands mean

  • Increased separation between the 3rd and 4th digits
  • Appears as:
    • Square palm
    • Fingers splayed, especially in coronal hand view
  • Subtle prenatally, often requires intentional assessment

Conditions classically associated

  • Achondroplasia
  • Hypochondroplasia (less obvious)
  • Occasionally pseudoachondroplasia (postnatal diagnosis usually)

Trident hands are not a feature of:

  • Lethal dysplasias
  • Growth restriction
  • Chromosomal aneuploidy
  • SHOX deficiency (hands are usually normal)
Feature Interpretation
FL/foot ratio 1.15 Non-lethal, mild disproportion
No classic dysplasia signs Rules out severe skeletal dysplasias
Missing lumbosacral widening Suggests abnormal vertebral growth
Suspected trident hands Points to FGFR3 spectrum
Progressive nature Consistent with late-manifesting dysplasia

Achondroplasia

  • Often looks normal until late second or third trimester
  • Disproportion becomes obvious late
  • Trident hands may be subtle prenatally
  • Lumbosacral narrowing is an early spinal clue

Hypochondroplasia

  • Even milder prenatally
  • Long bone shortening may be borderline
  • Craniofacial signs often absent prenatally
  • Frequently missed on routine scans
  • Foot–FL ratio reassures survival
  • Absence of lumbosacral widening is a red flag for vertebral dysplasia
  • Trident hands are a pattern clue, not an isolated anomaly
  • Together, they point toward a mild FGFR3-related skeletal disorder, most likely hypochondroplasia or evolving achondroplasia
  • Macrocephaly + frontal bossing → Achondroplasia
  • Normal head size → Hypochondroplasia or SHOX
  • Microcephaly → Think non-FGFR3 syndromic causes

When limb shortening is mild, spine and hands matter more than centiles.

Failure of lumbosacral widening and trident hands strongly favor FGFR3-related dysplasia, even when classic features are absent.

Minimal tibial bowing does not suggest:

  • Campomelic dysplasia (severe, lethal, multiple long bones)
  • Thanatophoric dysplasia (severe, rhizomelic, macrocephaly)
  • OI (would have fractures, poor mineralization)
  • FGFR3-related disorders (especially hypochondroplasia)
  • ACAN-related short stature
  • Some mild metaphyseal dysplasias

FGFR3 spectrum (Hypochondroplasia > Achondroplasia)

Why it fits

  • Mild, late-declaring limb shortening
  • Possible trident hands
  • Reduced lumbosacral widening
  • Can show subtle long-bone bowing
  • Autosomal dominant
  • Affected adults often report:
    • Short stature
    • Lumbar lordosis
    • Early degenerative spine disease
    • Hip and knee OA earlier than expected

Why hypochondroplasia fits better than achondroplasia

  • Achondroplasia usually obvious clinically in the parent
  • Hypochondroplasia is often underdiagnosed
  • Many adults are labeled "short with bad joints"

Limitation

  • Premature OA is common but not universal

ACAN-related short stature with early OA (very strong contender)

This is the key alternative you must consider now.

Why ACAN fits exceptionally well

  • Autosomal dominant
  • Mild limb shortening prenatally
  • Normal mineralization
  • Subtle metaphyseal changes
  • Can show mild tibial bowing
  • Hands often look normal or only subtly abnormal
  • Premature osteoarthritis is a hallmark
  • Adults often present first to orthopedics, not genetics
Feature Points toward
Foot–FL ratio 1.15 Non-lethal, mild dysplasia
No severe dysplasia signs Rules out lethal entities
Missing lumbosacral widening FGFR3 > ACAN
Suspected trident hands FGFR3
Minimal tibial bending FGFR3 or ACAN
Affected mother Autosomal dominant
Premature OA in mother ACAN or FGFR3

"The findings suggest a mild inherited condition affecting cartilage and bone growth. These conditions are compatible with normal intelligence and lifespan, but are associated with short stature and a higher likelihood of joint problems in adulthood."

  • Mild limb shortening
  • Foot–FL ratio ~1.15
  • Preserved mineralization
  • Subtle tibial bending
  • Missing lumbosacral widening
  • Suspected trident hands
  • Familial phenotype with premature OA
  • Normal sex differentiation
  • Normal scapulae

Hypochondroplasia (FGFR3)

Still strongly supported because:

  • Late-declaring, mild phenotype
  • Subtle bowing can occur
  • Trident hands + spinal configuration fit
  • Autosomal dominant
  • Adult phenotype often under-recognized

ACAN-related skeletal dysplasia with early OA

Now arguably equally strong:

  • Dominant inheritance
  • Mild prenatal changes
  • Tibial metaphyseal abnormalities
  • Normal scapulae
  • Premature osteoarthritis is a defining adult feature
  • Often missed prenatally unless family history is elicited

borderline limb shortening, preserved mineralization, and a family history of short stature or early osteoarthritis.

Feature FGFR3 spectrum (Achondroplasia / Hypochondroplasia) ACAN-related skeletal dysplasia
Inheritance Autosomal dominant (often de novo, can be inherited) Autosomal dominant (often familial)
Prenatal onset Usually late 2nd or 3rd trimester Often subtle, may be present from mid-gestation
Severity prenatally Achondroplasia: moderate; Hypochondroplasia: very mild Mild, often borderline or nonspecific
Pattern of limb shortening Predominantly rhizomelic Mild generalized or mesomelic
Foot–FL ratio Mildly increased (≈1.1–1.2) Usually normal to mildly increased
Bone mineralization Normal Normal
Long bone bowing Mild bowing can occur (esp. tibia/femur) Mild metaphyseal irregularity or subtle bowing
Hands Trident hand (highly suggestive) Usually normal or subtly broad
Spine (prenatal clue) Absent or reduced lumbosacral widening; early interpedicular narrowing Vertebral changes subtle; no classic lumbosacral pattern
Thorax Normal Normal
Scapulae Normal Normal
Craniofacial clues prenatally Often absent early; may evolve late Typically absent prenatally
Head circumference trend May increase late (macrocephaly) Usually normal
Evolution on serial scans Progressive disproportion over time Growth deceleration without classic dysplasia pattern
Associated visceral anomalies None typical None typical
Maternal phenotype Short stature, lumbar lordosis, early spine OA Premature osteoarthritis is a hallmark
Postnatal joint disease Common (spine, hips, knees) Very common and often early
Intelligence / lifespan Normal Normal
Best prenatal genetic test Targeted FGFR3 sequencing Targeted ACAN sequencing + CNV analysis
Why exome may miss it Mosaicism, coverage issues Structural variants, intronic variants

Why FGFR3 is missed on exome

A. Low-level mosaicism (very common in FGFR3)

FGFR3 disorders, especially:

  • Hypochondroplasia
  • Milder achondroplasia variants

are frequently mosaic, particularly when inherited from a mildly affected parent.

What happens technically

  • Exome pipelines often filter out variants below ~20–30% allele fraction
  • Mosaic variants may sit at 5–15%
  • Variant is present but discarded as sequencing noise

Targeted sequencing advantage

  • Much higher depth (500–2000×)
  • Mosaic variants are reliably detected

GC-rich and repetitive regions

FGFR3 has:

  • GC-rich exons
  • Regions prone to uneven capture

Exome capture bias

  • Poor probe hybridization
  • Dropout of key exons
  • Uneven coverage that passes "mean depth" QC but fails locally

A pathogenic variant can literally be in a low-coverage hole.

Targeted panels use:

  • Optimized probes
  • Redundant tiling
  • Better uniformity

Why ACAN is missed on exome (even more often)

ACAN is notoriously exome-unfriendly.

A. Structural variants and exon-level CNVs

Many pathogenic ACAN variants are:

  • Exon deletions or duplications
  • Multi-exon copy number changes
  • Frameshifts involving repetitive domains

Standard exome pipelines

  • Are not validated for single-gene CNV detection
  • Especially poor in large genes like ACAN

Targeted testing usually includes:

  • Dedicated CNV analysis
  • MLPA or NGS-based dosage calling

The classic FGFR3 mosaic miss

Prenatal findings

• Femur and tibia −1.8 to −2.2 SD (late 2nd trimester)

• Foot–FL ratio ~1.15

• Mild tibial bowing, normal mineralization

• Subtle trident hand appearance only after 28 weeks

• Spine initially normal; mild lumbar narrowing appears late

Family history

• Mother 148 cm, labelled "familial short stature"

• No formal diagnosis

Testing done

• Trio exome: reported negative

Why exome missed it

• Pathogenic FGFR3 variant present at ~12% allele fraction

• Filtered out as sequencing noise

• Mean coverage adequate, local coverage poor

Clue that should raise suspicion

• Progressive spine findings + trident hands

• Limb shortening declared late, not early

What made the diagnosis

• Targeted deep FGFR3 sequencing (800×)

• Mosaic hypochondroplasia variant detected

Teaching pearl

Late declaration + spine + hands = think FGFR3 mosaicism, not "mild constitutional".

ACAN with normal prenatal proportions

Prenatal findings

• Femur −1.5 SD, tibia −1.6 SD (stable across scans)

• No metaphyseal flaring

• No trident hands

• Spine length and shape normal

Family history

• Mother and maternal grandfather with early knee OA (30s–40s)

• Both short but proportionate

Testing done

• Prenatal exome: negative

• Postnatal microarray: normal

Why exome missed it

• Heterozygous multi-exon deletion in ACAN

• Exome CNV pipeline not validated for single-gene events

Clue that should raise suspicion

• Strong familial premature OA

• Stable, proportionate short stature

What made the diagnosis

• Targeted ACAN sequencing + exon-level CNV analysis

Teaching pearl

Normal prenatal anatomy does not exclude ACAN; history carries the weight.

The "normal mineralization" trap

Prenatal findings

• Mild limb shortening (−2 SD)

• Minimal tibial bowing

• Normal thorax

• Normal skull and mineralization

Initial interpretation

• "No skeletal dysplasia"

• Reassured after negative exome

Reality

• FGFR3 variant affecting regulatory region

• Poorly captured exon

Why exome missed it

• Capture dropout in GC-rich region

• Variant never sequenced adequately

What made the diagnosis

• Sanger sequencing of FGFR3 hotspot exons

Teaching pearl

Normal mineralization excludes lethality, not FGFR3.

ACAN filtered out by phenotype

Prenatal indication on requisition

• "Short long bones, rule out skeletal dysplasia"

Lab analysis behaviour

• Prioritised FGFR3, COL2A1, lethal dysplasias

• ACAN ranked low, variant classified VUS and not reported

Missed information

• Father with hip replacement at 42

• Two generations of short stature

What changed the outcome

• Re-analysis with updated clinical notes

• Same variant upgraded to pathogenic

Teaching pearl

ACAN is often missed because the story isn't told to the lab.

Placental vs fetal confusion

Scenario

• Mild limb shortening

• Discordant NIPT

• Normal amniocentesis

Assumption

• "Placental mosaicism explains everything"

Reality

• Fetal FGFR3 mosaicism, placenta normal

Why exome missed it

• Mosaicism confined to fetal tissues

• Low DNA input from amniocytes

What solved it

• Postnatal targeted sequencing from blood

Teaching pearl

CPM explains chromosomes, not single-gene dysplasias.

FGFR3 is missed because of mosaicism and coverage

ACAN is missed because of CNVs and filtering

Exome negativity ≠ absence of disease

Family history often outweighs fetal measurements